Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
Overview | Financials
Company Name | Amphastar Pharmaceuticals, Inc. |
Symbol | AMPH |
Currency | USD |
Price | 48.31 |
Market Cap | 2,351,527,898 |
Dividend Yield | 0% |
52-week-range | 36.56 - 65.92 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Yongfeng Zhang Ph.D. |
Website | https://www.amphastar.com |
An error occurred while fetching data.
About Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD